Gate Diagnostics to Feature Sequre at the Ocala Equine Conference

[Ocala, Florida] — Gate Diagnostics is excited to announce its first-time attendance at the Ocala Equine Conference on February 14th, where the company will highlight Sequre™, its rapid molecular testing platform for equine respiratory disease. Hosted at the Equestrian Manor on the grounds of the World Equestrian Center, the Ocala Equine Conference brings together a highly targeted audience of Florida-based equine veterinarians, providing a focused setting for meaningful technical and clinical discussions.

Respiratory disease remains a leading cause of morbidity and economic impact in horses, and timely, accurate diagnostics are essential for effective case management and biosecurity. Sequre is being developed to bring sensitive molecular testing closer to the point of care, reducing turnaround time and helping veterinarians make confident treatment and management decisions.

As a smaller, regionally focused meeting, the Ocala Equine Conference offers an excellent opportunity for Gate Diagnostics to build new relationships, gather direct feedback from practitioners, and better understand the needs of equine veterinarians in Florida. The company looks forward to engaging with attendees and continuing to advance the development of Sequre as part of its broader mission to deliver accessible, high-performance veterinary tools.